EMA: Awiqli (Icodec) marketing authorisation the approval to market a medicine in one, several or all european union member states
03/06/2024
Leggi
Breaking news
Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex
Kitaoka K, Yano Y, Nagasu H, et al.
BMJ Open Diabetes Res Care. Pub. online 30 May 2024.
Leggi
Adherence to a Mediterranean diet is associated with a lower risk of diabetic kidney disease among individuals with hyperglycemia: a prospective cohort study
Qu C, Zhao J, Lai J, et al.
BMC Med. Pub. online 3 June 2024.
Leggi
Caesarean section and risk of type 1 diabetes
Singh T, Weiss A, Vehik K, et al.
Diabetologia. Pub. online 31 May 2024.
Leggi
Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study
Mayén AL, Sabra M, Aglago EK, et al.
BMC Med. Pub. online 3 June 2024.
Leggi
Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial
Knowler WC, Chen H, Bahnson JL, et al.
BMJ Open Diabetes Res Care. Pub. online 30 May 2024.
Leggi
Metformin for preventing the progression of chronic kidney disease
El-Damanawi R, Stanley IK, Staatz C, et al.
Cochrane Database Syst Rev. Pub. online 4 June 2024.
Leggi
Effect of interpregnancy interval on the risk of gestational diabetes mellitus during a second pregnancy
Deng Y, Xu C, Yang A, et al.
BMC Pregnancy Childbirth. Pub. online 4 June 2024.
Leggi
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study
Vatanen T, de Beaufort C, Marcovecchio ML, et al.
Diabetologia. Pub. online 4 June 2024.
Leggi
Long-term changes in frailty and incident type 2 diabetes: a prospective cohort study based on the UK Biobank
Sun Y, Li W, Zhou Y, et al.
Diabetes Obes Metab. Pub. online 24 May 2024.
Leggi